CLINICAL_TRIALS
trial_result
· 2017-05-17
Clinical Trial Update: Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone [Phase 2]
Summary
A Phase 2 trial of TAK-448 in middle-aged and older men with low testosterone was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Low Testosterone | Phase 2 | Status: TERMINATED | Results posted: 2017-05-17